The prognosis of estrogen receptor-negative (ER−) breast cancer is worse than estrogen receptor-positive (ER+) breast cancer in most situations, but ER− breast cancer patients do not always have a poor clinical outcome. The gene discussed is ESR1; the disease is breast carcinoma.